Chiasma, Inc. (CHMA) financial statements (2020 and earlier)

Company profile

Business Address 460 TOTTEN POND ROAD
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2013153741
Cash and cash equivalents2013153741
Other undisclosed current assets86495458110
Total current assets:106626995151
Noncurrent Assets
Property, plant and equipment00011
Other noncurrent assets11111
Total noncurrent assets:11122
TOTAL ASSETS:107637097153
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities910575
Accounts payable32110
Accrued liabilities78465
Estimated litigation liability 19   
Other liabilities0 22 
Other undisclosed current liabilities    2
Total current liabilities:929787
Noncurrent Liabilities
Long-term debt and lease obligation0    
Operating lease, liability0
Liabilities, other than long-term debt    0
Liability for uncertainty in income taxes    0
Other undisclosed noncurrent liabilities11133
Total noncurrent liabilities:11134
Total liabilities:102971110
Stockholders' equity
Stockholders' equity attributable to parent97346286143
Common stock00000
Additional paid in capital357271268264260
Accumulated other comprehensive income (loss)0(0)(0)(0)0
Accumulated deficit(261)(237)(205)(179)(117)
Total stockholders' equity:97346286143
TOTAL LIABILITIES AND EQUITY:107637097153

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Operating expenses(34)(32)(28)(61)(35)
Operating loss:(34)(32)(28)(61)(35)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
1111(0)
Interest and debt expense (0)(0)(0)(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)    
Loss from continuing operations before equity method investments, income taxes:(32)(31)(28)(61)(36)
Other undisclosed income from continuing operations before income taxes00000
Loss from continuing operations before income taxes:(32)(31)(27)(61)(36)
Income tax expense (benefit)001(0)(0)
Net loss attributable to parent:(32)(31)(27)(61)(36)
Preferred stock dividends and other adjustments    (0)
Net loss available to common stockholders, diluted:(32)(31)(27)(61)(36)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(32)(31)(27)(61)(36)
Other comprehensive income (loss)00(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(32)(31)(27)(61)(36)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: